SGRY · NASDAQ · Medical - Care Facilities

Surgery Partners (SGRY)

Operates physician-partnered surgery centers and short-stay hospitals for planned procedures.

$14.65
vs last close−1.15 (−7.25%)
Loading prices…

Surgery Partners, Inc.SGRY
Health Care

Operates ambulatory surgery centers, short-stay surgical hospitals, anesthesia services, urgent care facilities, and physician practices across the United States. Revenue comes mainly from facility fees under physician and health-system partnerships, with results tied to procedure volumes, payer reimbursement, and continued physician participation.

Provides planned surgical care through a U.S. network of ambulatory surgery centers, short-stay surgical hospitals, anesthesia services, urgent care facilities, and multispecialty physician practices. The portfolio spans orthopedics and pain management, gastroenterology, ophthalmology, and general surgery.

Earns mainly facility fees covering operating rooms, recovery areas, equipment, supplies, nursing, and medications; physicians generally bill their professional fees separately. Partnerships with physicians, physician groups, and health systems combine local clinical relationships with centralized financial, marketing, payer-contracting, acquisition, and facility-development support.

Revenue depends on private-insurance and government reimbursement, favorable payer contracts, continued use by affiliated physicians who are usually not employees, and compliance with healthcare and facility-licensing rules. Operations remain concentrated in the United States and are reported within the Surgical Facilities segment.

Company facts

CEOJ. Eric Evans
ListedOct 1, 2015
ExchangeNASDAQ
HeadquartersBrentwood, TN
CountryUnited States
Employees16,000
CIK0001638833
ISINUS86881A1007

Market cap$2.07B
EPS (ttm)−$0.6900
P/E (ttm)−22.90
ROE-5.2%
P/B1.24
P/S0.6139
Dividend yieldDiv yield
Beta0.69vs XLV 0.48

Price target$18.00+13.9%Average of 22 analysts
ConsensusBuy14 of 22 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 11, 2026Raymond JamesTarget
Target:
Target: $18
Aug 11, 2026RBC CapitalReiterate
Rating: Target: $20
Rating: OutperformTarget: $19
May 6, 2026JefferiesTarget
Target: $15
Target: $17
Apr 20, 2026JefferiesTarget
Target: $16.25
Target: $15
Mar 11, 2026US Capital AdvisorsTarget
Target:
Target: $21

Next report
Nov 9, 26
in 47 days
EPS estimate
$0.09
Revenue estimate
$848.5M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.44$0.04$0.17$0.13$0.12−$0.03$0.10Pending
Estimate$0.38$0.08$0.16$0.19$0.31−$0.15$0.06$0.09
Surprise+15.8%−50.0%+6.3%−31.6%−61.3%+80.0%+72.6%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$864.4M$776.0M$826.2M$821.5M$885.0M$810.9M$848.9MPending
Estimate$800.1M$777.1M$823.5M$866.5M$866.8M$797.7M$830.0M$848.5M
Surprise+8.0%−0.1%+0.3%−5.2%+2.1%+1.7%+2.3%
Estimate$0.09
ReportedDue Nov 9, 2026
Estimate$848.5M
ReportedDue Nov 9, 2026
View details

Debt to equity240.50%
Current ratio194.60%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$770.4M$864.4M$776.0M$826.2M$821.5M$885.0M$810.9M$848.9M
Net income−$31.7M−$108.5M−$37.7M−$2.5M−$22.7M−$15.0M−$35.9M−$15.0M
Net margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$60.9M$127.1M$61.9M$111.7M$105.7M$110.2M$82.4M$102.1M
YoY growth−26.3%+25.3%−18.6%+31.7%+73.6%−13.3%+33.1%−8.6%

Balance sheet, Jun 30, 2026Cash & short-term investments $216.7M · Total debt $4.02B · Total assets $8.05B · Shareholders' equity $1.67B

Revenue
$848.9M
Operating income
$102.1M
Net income
−$15.0M
View details

No dividends on record.

Institutions121.37%158.89M shares
199 holders · as of Jun 30, 2026
Insiders1.88%2.46M shares
17 holders · as of Aug 20, 2026
Strategic holders9.96%13.04M shares
1 holder · as of Nov 14, 2025
Adds to133.21%

130.92M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 133.21%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Bain Capital Investors LLCInstitution
38.15%49.95Mas of Jun 30, 2026
BCPE Seminole Holdings II Intermediate, LPInstitution
22.96%30.06Mfiled Jun 17, 2025
Jupiter Topco LLCInstitution
10.60%13.88Mas of Jun 30, 2026
Janus Henderson Group PLCStrategic
9.96%13.04Mfiled Nov 14, 2025
Pentwater Capital Management LPInstitution
8.88%11.63Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 18, 2026Teresa DeLucadirector+21,250$14.34
Mar 12, 2026Jennifer Baldockofficer: Chief Admin & Dev Officer−5,798$13.17
Mar 16, 2026Jason Eric Evansofficer: Chief Executive Officer−20,400$12.47
Mar 16, 2026David T. Dohertyofficer: Chief Financial Officer−8,867$12.50
Mar 13, 2026Marissa Brittenhamofficer: Chief Strategy Officer−3,657$12.54
View details

  • Tenet Healthcare

    Nation's largest ASC platform via USPI; 533 centers across 37 states

  • UnitedHealth Group

    Largest US payer operating ~344 ASCs via Optum's SCA Health subsidiary

  • HCA Healthcare

    Surgery Ventures arm co-owns ~150 ASCs with 3,400+ physician partners nationally

  • Community Health Systems

    Hospital chain with ~36–47 satellite ASCs competing in orthopedics and GI

Compare

CompanyPriceChange
Surgery Partners$14.65−7.25%$2.07B35.00.6+2.8%
Tenet Healthcare$257.80−1.63%$21.10B10.112.41.0+6.8%
UnitedHealth Group$370.56−0.64%$338.69B24.017.40.8+0.4%
HCA Healthcare$437.43−0.16%$94.85B14.714.31.2+8.7%
Community Health Systems$3.03+0.17%$425.8M0.0−9.8%
Median14.714.30.9+3.6%